Pneumocystis carinii pneumonia associated with adrenocorticotropic hormone treatment for infantile spasms

1992 ◽  
Vol 151 (11) ◽  
pp. 867-867 ◽  
Author(s):  
R. Shamir ◽  
B. Z. Garty
Keyword(s):  
Pneumocystis Carinii Pneumonia ◽  
Adrenocorticotropic Hormone ◽  
Pneumocystis Carinii ◽  
Hormone Treatment ◽  
Infantile Spasms

Risk of infection during adrenocorticotropic hormone treatment in infants with infantile spasms

1993 ◽  
Vol 12 (11) ◽  
pp. 913-915 ◽  
Author(s):  
RAANAN SHAMIR ◽  
BEN-ZION GARTY ◽  
AVINOAM RACHMEL ◽  
SARA KIVITY ◽  
GERSHON ALPERT
Keyword(s):  
Adrenocorticotropic Hormone ◽  
Hormone Treatment ◽  
Infantile Spasms ◽  
Risk Of Infection

scholarly journals Infantile Spasms in Children With Down Syndrome: Identification and Treatment Response

2019 ◽  
Vol 6 ◽  
pp. 2333794X1882193 ◽  
Author(s):  
Dee Daniels ◽  
Kelly Knupp ◽  
Tim Benke ◽  
Kristine Wolter-Warmerdam ◽  
Maura Moran ◽  
...  
Keyword(s):  
Down Syndrome ◽  
Adrenocorticotropic Hormone ◽  
Early Recognition ◽  
Heart Defects ◽  
Hormone Treatment ◽  
Magnetic Resonance Images ◽  
Infantile Spasms ◽  
Single Institution ◽  
First Line ◽  
Children With Down Syndrome

Objectives. To evaluate infantile spasms in children with Down syndrome including assessment of efficacy of treatments, presence of treatment lag, and to identify risk factors that may predict the occurrence of infantile spasms in this population. Methods. Medical charts, electroencephalograms, and brain magnetic resonance images were evaluated in 37 children treated for infantile spasms at a single institution from 2005 to 2015. Results. Mean age at diagnosis was 9.16 months, with an average 1.38-month lag from spasms onset to start of medication. Prevalence of heart defects and pulmonary hypertension were significantly higher in those with infantile spams compared with those without. Eighty-one percent receiving adrenocorticotropic hormone as initial treatment experienced remission within 2 weeks, 94.1% had remission at 3 months compared with 18.8% at 2 weeks and 35.3% at 3 months for other first-line treatments. Type of treatment was the only predictor of good outcome. Conclusions. Results stress the importance of early recognition and adrenocorticotropic hormone treatment for this seizure disorder in children with Down syndrome.

scholarly journals Vigabatrin Therapy for Infantile Spasms in a Case of Cardiofaciocutaneous Syndrome with Cardiac Hypertrophy Developing during Adrenocorticotropic Hormone Treatment

2016 ◽  
Vol 83 (4) ◽  
pp. 167-171 ◽  
Author(s):  
Takayuki Hatori ◽  
Yohei Sugiyama ◽  
Shinichiro Yamashita ◽  
Yuka Hirakubo ◽  
Kazuhito Nonaka ◽  
...  
Keyword(s):  
Cardiac Hypertrophy ◽  
Adrenocorticotropic Hormone ◽  
Hormone Treatment ◽  
Infantile Spasms ◽  
Cardiofaciocutaneous Syndrome

Pneumocystis carinii pneumonia in infants givenadrenocorticotropic hormone for infantile spasms

1987 ◽  
Vol 110 (6) ◽  
pp. 901-903 ◽  
Author(s):  
Lynne M. Quittell ◽  
Margaret Fisher ◽  
Catherine M. Foley
Keyword(s):  
Pneumocystis Carinii Pneumonia ◽  
Pneumocystis Carinii ◽  
Infantile Spasms

Pneumocystis carinii pneumonia

JAMA ◽  
1965 ◽  
Vol 194 (10) ◽  
pp. 1129-1129
Keyword(s):  
Pneumocystis Carinii Pneumonia ◽  
Pneumocystis Carinii
Sign in / Sign up

Export Citation Format

Share Document